DEAR DR. ROACH: I am a 77-year-old woman in good health. I walk daily. The only prescribed medications I am on are two different eye drops for glaucoma. My eye pressure is under control; I have it ...
Glaucoma is a group of eye diseases, most of which are characterized by increased pressure within the eye. This elevated pressure, caused by a backup of fluid, can gradually damage the optic nerve.
Glaucoma refers to a group of common eye diseases that damage the optic nerve and cause vision loss if left untreated.
Glaucoma can cause damage to the optic nerve if left untreated, making frequent eye appointments vital for catching it quickly. So a lot of people think that glaucoma is a disease in which they have ...
AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk factors for developing glaucoma ...
GLP-1 receptor agonists may reduce glaucoma risk in T2D patients, though the reduction was nonsignificant. The review included five high-quality observational studies with over 2.5 million ...
Glaucoma represents one of medicine’s most paradoxical challenges—a leading cause of irreversible blindness worldwide that progresses so silently many patients have no idea they’re affected until ...
Although primary open-angle glaucoma (POAG) is the leading cause of blindness in people over the age of 55, there remains no cure for the disease and its biological mechanisms are not well understood.
Diabetic patients treated with GLP-1 receptor agonists (GLP-1RAs) had a significantly lower risk of developing glaucoma as compared with metformin, a large retrospective cohort study showed. Patients ...
Please provide your email address to receive an email when new articles are posted on . GLP-1RA use was associated with a 19% reduction in risk for glaucoma in patients with type 2 diabetes. Long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results